Skip to content

Author

Mélanie Menara

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jun 2026

Cost effectiveness and public health impact of PCV20 among adults in France.

PCV20 is a cost-saving alternative to the PCV13 → PPV23 sequence for at-risk adults in France and provides substantial public health gains and represents a highly cost-effective strategy relative to commonly cited French vaccine HTA benchmarks.

S. Fiévez, Mélanie Menara, E. Blanc et al. · 0 citations